Pulmonary carcinoid tumours: indolent but not benign

Oncology
Sara De DossoElena Verzoni

Abstract

The aim of this retrospective study was to analyse the malignant behaviour of low-grade pulmonary neuroendocrine tumours (NETs) treated at our institution. We reviewed 48 consecutive patients with pulmonary NETs referred to our Medical Oncology Unit between 1998 and 2006, including 33 subjects with typical carcinoids (TCs) and 15 with atypical carcinoids (ACs). At diagnosis, there were 37 metastatic and 11 non-metastatic patients. Medical treatments used were somatostatin analogues, combined chemotherapy, within study protocols, 5-fluorouracil/dacarbazine/epiadriamycin (FDE), and oxaliplatin plus capecitabine (XELOX). Median disease-free survival was 72 months for the TC patients and 38 months for the AC patients. Actuarial 5-year survival was 93% for those with TCs and 73% for those with ACs. The mean overall survival was 68 months for the non-metastatic patients (78 months for TC patients and 58 months for AC patients) and 36 months for patients with advanced disease (42 and 32 months, respectively). Cell type is the strongest determinant of prognosis, and the degree of malignancy increases from TCs to ACs. Moreover, the prognosis of metastatic pulmonary carcinoids is not as good as expected. Our analysis suggests that patien...Continue Reading

Citations

Sep 18, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L RighiM Papotti
Dec 3, 2011·Endocrine-related Cancer·Federico Gatto, Leo J Hofland
Sep 17, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Michael K AsieduDennis A Wigle
Sep 16, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Diego Marquez-Medina, Sanjay Popat
Jul 24, 2012·Cancer Treatment Reviews·Cesare GridelliFerdinando Riccardi
Jul 28, 2009·The Journal of Surgical Research·Holly L NevilleJuan E Sola
May 15, 2012·Biochimica Et Biophysica Acta·Dorian R A SwartsErnst-Jan M Speel
Jul 1, 2017·Frontiers in Oncology·Barbara Melosky
May 21, 2015·American Society of Clinical Oncology Educational Book·David E GerberAfshin Dowlati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
R SrirajaskanthanMartyn Caplin
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
William D Travis
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
Birgit Guldhammer SkovAnders Mellemgaard
Cancer
Bjorn I GustafssonIrvin M Modlin
© 2022 Meta ULC. All rights reserved